glp-1 agonist therapy Receptor Agonists as Treatments for Type 2 Diabetes Top GLP-1 Agonists Balance Weight

To view a copy of this licence, visit About this article Cite this article Quddos, F., Fowler, M., de Lima Bovo, A.C

Adverse Effects from GLP-1 Therapeutic Use, Dosing Errors, & Overdose GLP-1 agonists often cause gastrointestinal side effects, occurring in up to 50% of patients in some instances

Pathway key points: GLP-1RA therapy is used within a defined preconception optimization window

doi: 10.1002/dmrr.3168

First-time prescribing of AOMs was about the same in December 2025, relative to September 2025 (-1.0%)

All glucocorticoids are Prohibited during the In-Competition period when administered by any injectable, oral [including oromucosal (e.g